Anti-IL-13 Therapies

Anti-IL-13 therapies are treatments designed to target and block a protein called interleukin-13 (IL-13), which plays a key role in allergic and inflammatory responses, particularly in conditions like asthma and atopic dermatitis. By inhibiting IL-13, these therapies help reduce airway inflammation, improve breathing, and lessen symptoms related to allergic diseases. They often involve monoclonal antibodies—specialized proteins engineered to specifically bind and neutralize IL-13. Overall, anti-IL-13 treatments offer targeted options to control inflammation and improve quality of life for individuals with certain allergic conditions.